Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 1.005
-0.025 (-2.43%)
Aug 8, 2025, 5:35 PM CET
Catalent Market Cap
Transgene has a market cap or net worth of €133.04 million as of August 8, 2025. Its market cap has increased by 23.92% in one year.
Market Cap
133.04M
Enterprise Value
126.76M
Revenue
6.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.01
Market Cap Chart
Since March 30, 1998, Transgene's market cap has decreased from 151.86M to 133.04M, a decrease of -12.39%. That is a compound annual growth rate of -0.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 133.04M | 48.23% |
| Dec 31, 2024 | 89.75M | -34.86% |
| Dec 29, 2023 | 137.78M | -16.38% |
| Dec 30, 2022 | 164.76M | -33.52% |
| Dec 31, 2021 | 247.84M | 79.73% |
| Dec 31, 2020 | 137.90M | 6.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 116.62B |
| Sanofi | 98.69B |
| Sartorius Stedim Biotech | 16.23B |
| bioMérieux | 14.71B |
| Eurofins Scientific SE | 11.81B |
| Ipsen | 8.77B |
| ABIVAX Société Anonyme | 4.56B |
| Virbac | 2.78B |